BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2212 related articles for article (PubMed ID: 28153662)

  • 1. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstetric outcomes in patients with primary thrombotic and obstetric antiphospholipid syndrome and its relation to the antiphospholipid antibody profile.
    Högdén A; Antovic A; Berg E; Bremme K; Chaireti R
    Lupus; 2019 Jun; 28(7):868-877. PubMed ID: 31132916
    [No Abstract]   [Full Text] [Related]  

  • 4. Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study.
    Fischer-Betz R; Specker C; Brinks R; Schneider M
    Lupus; 2012 Oct; 21(11):1183-9. PubMed ID: 22685017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid syndrome characteristics and adverse pregnancy outcomes after 20 weeks of pregnancy.
    Gabbay-Benziv R; Zafrir-Danieli H; Blickstein D; Shmueli A; Salman L; Hadar E
    Int J Gynaecol Obstet; 2018 Aug; 142(2):214-220. PubMed ID: 29676461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome.
    Simchen MJ; Dulitzki M; Rofe G; Shani H; Langevitz P; Schiff E; Pauzner R
    Acta Obstet Gynecol Scand; 2011 Dec; 90(12):1428-33. PubMed ID: 21729009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between antiphospholipid antibodies and late fetal loss: A systematic review and meta-analysis.
    Xu J; Chen D; Duan X; Li L; Tang Y; Peng B
    Acta Obstet Gynecol Scand; 2019 Dec; 98(12):1523-1533. PubMed ID: 31131876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticardiolipin Positivity Is Highly Associated With Intrauterine Growth Restriction in Women With Antiphospholipid Syndrome.
    Xi F; Cai Y; Lv M; Jiang Y; Zhou F; Chen Y; Jiang L; Luo Q
    Clin Appl Thromb Hemost; 2020; 26():1076029620974455. PubMed ID: 33296221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group.
    Branch DW; Peaceman AM; Druzin M; Silver RK; El-Sayed Y; Silver RM; Esplin MS; Spinnato J; Harger J
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):122-7. PubMed ID: 10649166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.
    Del Ross T; Ruffatti A; Visentin MS; Tonello M; Calligaro A; Favaro M; Hoxha A; Punzi L
    J Rheumatol; 2013 Apr; 40(4):425-9. PubMed ID: 23418380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celiac disease and obstetric complications: a systematic review and metaanalysis.
    Saccone G; Berghella V; Sarno L; Maruotti GM; Cetin I; Greco L; Khashan AS; McCarthy F; Martinelli D; Fortunato F; Martinelli P
    Am J Obstet Gynecol; 2016 Feb; 214(2):225-234. PubMed ID: 26432464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
    Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L
    Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
    Alijotas-Reig J; Casellas-Caro M; Ferrer-Oliveras R; Llurba-Olive E; Hermosilla E; Vilardell-Tarres M; Cabero-Roura L
    Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody profiles for the diagnosis of antiphospholipid syndrome.
    Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S
    Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile.
    Latino JO; Udry S; Aranda FM; Perés Wingeyer SDA; Fernández Romero DS; de Larrañaga GF
    Lupus; 2017 Aug; 26(9):983-988. PubMed ID: 28173738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER).
    Laíño-Piñeiro MC; Rúa-Figueroa I; Jiménez N; Lozano MJC; Martínez-Barrio J; Serrano B; Galindo-Izquierdo M; Nack A; Loricera J; Tomero-Muriel E; Ibáñez-Barceló M; Vázquez NM; Manrique-Arija S; Lorenzo NA; Narváez J; Rosas J; Menor-Almagro R; Martínez-Taboada VM; Aurrecoechea-Aguinaga E; Horcada L; Ruiz-Lucea E; Raya E; Toyos FJ; Expósito L; Vela P; Freire-González M; Moriano-Morales C; Bonilla-Hernán G; Ibáñez TC; Lozano-Rivas N; Moreno M; Andreu JL; Ubiaga CLI; Torrente-Segarra V; Valls E; Velloso-Feijoo ML; Alcázar JL; Pego-Reigosa JM
    Semin Arthritis Rheum; 2023 Aug; 61():152232. PubMed ID: 37348350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the addition of anti-β2-glycoprotein to the classification of antiphospholipid syndrome in predicting adverse pregnancy outcome.
    Oron G; Ben-Haroush A; Goldfarb R; Molad Y; Hod M; Bar J
    J Matern Fetal Neonatal Med; 2011 Apr; 24(4):606-9. PubMed ID: 20874430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.
    Lazzaroni MG; Fredi M; Andreoli L; Chighizola CB; Del Ross T; Gerosa M; Kuzenko A; Raimondo MG; Lojacono A; Ramazzotto F; Zatti S; Trespidi L; Meroni PL; Pengo V; Ruffatti A; Tincani A
    Front Immunol; 2019; 10():1948. PubMed ID: 31475009
    [No Abstract]   [Full Text] [Related]  

  • 20. Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study.
    Mekinian A; Alijotas-Reig J; Carrat F; Costedoat-Chalumeau N; Ruffatti A; Lazzaroni MG; Tabacco S; Maina A; Masseau A; Morel N; Esteve-Valverde EE; Ferrer-Oliveras R; Andreoli L; De Carolis S; Josselin-Mahr L; Abisror N; Nicaise-Roland P; Tincani A; Fain O;
    Autoimmun Rev; 2017 Jul; 16(7):730-734. PubMed ID: 28478081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 111.